RedHill Biopharma and IntelGenx Submit Response to FDA CRL for RHB-103 Migraine Oral-Film

[GlobeNewswire] – TEL-AVIV, Israel — RedHill Biopharma Ltd. (RedHill), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage drugs, today … more

View todays social media effects on RDHL

View the latest stocks trending across Twitter. Click to view dashboard

See who Redhill is hiring next, click here to view